Zevalin-BEAM/BEAC With Autologous Stem Cell Support as Consolidation in First Line Treatment of Mantle Cell Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00514475
Recruitment Status : Completed
First Posted : August 10, 2007
Last Update Posted : May 4, 2012
Information provided by (Responsible Party):
Oslo University Hospital